gyki 52466 has been researched along with Benign Psychomotor Epilepsy, Childhood in 2 studies
GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suzuki, F | 1 |
| Heinrich, C | 1 |
| Boehrer, A | 1 |
| Mitsuya, K | 1 |
| Kurokawa, K | 1 |
| Matsuda, M | 1 |
| Depaulis, A | 1 |
| Domínguez, MI | 1 |
| Blasco-Ibáñez, JM | 1 |
| Crespo, C | 1 |
| Nacher, J | 1 |
| Marqués-Marí, AI | 1 |
| Martínez-Guijarro, FJ | 1 |
2 other studies available for gyki 52466 and Benign Psychomotor Epilepsy, Childhood
| Article | Year |
|---|---|
Glutamate receptor antagonists and benzodiazepine inhibit the progression of granule cell dispersion in a mouse model of mesial temporal lobe epilepsy.
Topics: Animals; Benzodiazepines; Cell Count; Dentate Gyrus; Disease Models, Animal; Dizocilpine Maleate; Ep | 2005 |
Neural overexcitation and implication of NMDA and AMPA receptors in a mouse model of temporal lobe epilepsy implying zinc chelation.
Topics: Animals; Benzodiazepines; Cell Death; Chelating Agents; Disease Models, Animal; Ditiocarb; Dizocilpi | 2006 |